ArticleZeitschrift fur medizinische Physik2026
A Novel Quantitative Analysis in Myocardial Perfusion Imaging: How does it compare to the "Golden Eye"?
Article in Zeitschrift fur medizinische Physik, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From photons and their detectors, ultra short and "longer" times to tiny and giant PETs, golden eyes, AI and surgical probes - Nuclear Medicine has it all.Zeitschrift fur medizinische Physik · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myocardial Perfusion Imaging is widely used to evaluate left ventricular perfusion in patients with ischemic heart disease. Semi-quantitative scores, such as Total Perfusion Deficit (TPD), are frequently used for the assessment of extent and severity of disease. TPD scores are based on a frequentist analysis of tracer distribution in perfusion polar maps, which are 2D polar representations of radiopharmaceutical tracer uptake in the left ventricular cardiac wall. In this paper, we propose a novel quantification method for MPI examinations. Our method approaches the problem from an inverse perspective to TPD, allowing the assessment of the severity and extension of abnormal perfusion from the synergetic contribution of all the left ventricular tracer uptake in a polar map. We analytically demonstrate that TPD can be viewed as a specific instance of a broader approach. Furthermore, we explore how to establish the quantitative analysis in a general approach. To test our new method, we leveraged a standard deep learning architecture for the prediction of abnormal perfusion and used gradient-based class activation maps as a measure of the abnormal perfusion territory, which facilitated the quantification of both the severity and extent of the perfusion deficit. In the absence of ground-truth data such as survival rates or major adverse cardiovascular events (MACE) criteria, our results demonstrate both statistical and visual consistency with the conventional TPD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.